Figure 4.

Alleviation of infarct size on phloroglucinol treatment. Diabetic rats showed an increase (a) in infarct size compared to normal rats, which was significantly reduced (b) on phloroglucinol treatment. Values are represented as means ± SEM (n = 6). Significance was assessed by one‐way ANOVA followed by Dunnet's multiple comparison test: a, vs normal control group; b, vs diabetic control group. NC, normal control; DC, diabetic control; Phloro(100), 100 mg/kg phloroglucinol; Phloro(200), 200 mg/kg phloroglucinol